Exposure Of Bisphenol Analogues In Chronic Kidney Disease and Dialysis Patients

Completed

• Conditions: Chronic Kidney Diseases; Hemodialysis Complication

• Registration Number: NCT04100421
• Lead Sponsor: Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University

Brief Summary

In this retrospective study, the serum levels of Bisphenol A (BPA) and three BPA analogs, namely, bisphenol B (BPB), bisphenol S (BPS), and bisphenol F (BPF), in patients with CKD, patients on dialysis therapy and healthy control were investigated to find out if BPA and BPA analogs accumulates in patients with chronic kidney disease (CKD), and if hemodialysis filters contribute to bisphenol burden in patients on hemodialysis (HD).

Detailed Description

Not available

Study Timeline

• Study Start: 2017-06-01
• Primary Completion: 2017-12-30
• Study Completion: 2018-06-30
• Status Verified: 2019-09
• Study First Submitted: 2019-09-21
• Study First Submitted QC: 2019-09-21
• Last Update Submitted: 2019-09-21
• Study First Posted: 2019-09-24
• Last Update Posted: 2019-09-24

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 154

Inclusion Criteria

• age 18; informed consent

Exclusion Criteria

• absence of active inflammatory, infectious, malignant diseases, acute chronic kidney disease, or pregnancy at the initiation or during the study

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Death	2017.01-2018.06

Trial Locations

Locations (1)

Shanghai Ninth People's Hospital; 🇨🇳 Shanghai, China